{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:17:32Z","timestamp":1789654652728,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.nbd.2009.10.023","type":"journal-article","created":{"date-parts":[[2009,11,8]],"date-time":"2009-11-08T04:15:34Z","timestamp":1257653734000},"page":"434-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":246,"title":["The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic\u2013ischemic brain damage in mice is mediated by CB2 and adenosine receptors"],"prefix":"10.1016","volume":"37","author":[{"given":"A.","family":"Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Tol\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Martinez-Orgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.10.023_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(01)01220-1","article-title":"Adenosine A(1) receptor agonism in the immature rat brain and heart","volume":"426","author":"Aden","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2009.10.023_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.STR.0000060204.67672.8B","article-title":"Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice","volume":"34","author":"Aden","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2009.10.023_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the non-psychoactive cannabinoid cannabidiol in hypoxic\u2013ischemic newbornpiglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2009.10.023_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2009.10.023_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2006.10.053","article-title":"Cerebral hypoxia\u2013ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain","volume":"412","author":"Ashton","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2009.10.023_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0028-3908(97)00139-1","article-title":"Neonatal cerebral hypoxia\u2013ischemia: the effect of adenosine receptor antagonists","volume":"36","author":"Bona","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2009.10.023_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-540-89615-9_10","article-title":"A3 adenosine receptor: pharmacology and role in disease","volume":"193","author":"Borea","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2009.10.023_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(03)00569-X","article-title":"Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils","volume":"346","author":"Braida","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2009.10.023_bib9","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.10.023_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","article-title":"Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and \u201cfine tuning\u201d modulation","volume":"83","author":"Chen","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2009.10.023_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(00)00033-3","article-title":"Adenosine: does it have a neuroprotective effect after all?","volume":"33","author":"de Mendonca","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.nbd.2009.10.023_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2009.10.023_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jneumeth.2005.01.005","article-title":"Immature rat brain slices exposed to oxygen\u2013glucose deprivation as an in vitro model of neonatal hypoxic\u2013ischemic encephalopathy","volume":"145","author":"Fernandez-Lopez","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2009.10.023_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","article-title":"Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic\u2013ischemic brain damage in newborn rats","volume":"60","author":"Fernandez-Lopez","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2009.10.023_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1203\/PDR.0b013e318123fbb8","article-title":"The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic\u2013ischemic encephalopathy in newborn rats","volume":"62","author":"Fernandez-Lopez","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2009.10.023_bib16","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMra041996","article-title":"Neonatal brain injury","volume":"351","author":"Ferriero","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2009.10.023_bib17","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.10.023_bib18","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14","author":"Hasko","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2009.10.023_bib19","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.10.023_bib20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.neuropharm.2008.06.040","article-title":"Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box 1-inhibiting mechanism","volume":"55","author":"Hayakawa","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2009.10.023_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2004.09.006","article-title":"Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells","volume":"48","author":"Lee","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2009.10.023_bib22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2009.10.023_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/157340806777934784","article-title":"Nitric oxide synthase as a target for the prevention of hypoxic\u2013ischemic newborn brain damage","volume":"2","author":"Martinez-Orgado","year":"2006","journal-title":"Curr. Enzym. Inhib"},{"key":"10.1016\/j.nbd.2009.10.023_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157488907780832724","article-title":"The seek of neuroprotection: introducing cannabinoids","volume":"2","author":"Martinez-Orgado","year":"2007","journal-title":"Recent Patents CNS Drug Discov."},{"key":"10.1016\/j.nbd.2009.10.023_bib25","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2014recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.nbd.2009.10.023_bib26","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1073\/pnas.0537849100","article-title":"Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release","volume":"100","author":"Mereu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.10.023_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/nen.0b013e3180517477","article-title":"Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration","volume":"66","author":"Minghetti","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.10.023_bib28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2009.10.023_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jnr.10165","article-title":"Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures","volume":"67","author":"Molina-Holgado","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.10.023_bib30","series-title":"Cannbinoids","first-page":"32","article-title":"The pharmacology and therapeutic potential of cannabidiol","author":"Pertwee","year":"2004"},{"key":"10.1016\/j.nbd.2009.10.023_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2009.10.023_bib32","first-page":"346","article-title":"Adenosine and brain ischemia","volume":"4","author":"Rudolphi","year":"1992","journal-title":"Cerebrovasc. Brain Metab Rev."},{"key":"10.1016\/j.nbd.2009.10.023_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2004.10.003","article-title":"The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro","volume":"159","author":"Sacerdote","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.10.023_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.10.023_bib35","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1073\/pnas.0804852105","article-title":"S-nitrosylation\/activation of COX-2 mediates NMDA neurotoxicity","volume":"105","author":"Tian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.10.023_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jnr.10294","article-title":"Caspases on the brain","volume":"69","author":"Troy","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.10.023_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0028-3908(88)90083-4","article-title":"Changes in neurotrasmitter release at a neuromuscular junction of the lobster caused by cannabinoids","volume":"27","author":"Turkanis","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2009.10.023_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0074-7742(07)82003-4","article-title":"Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation","volume":"82","author":"Vesce","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2009.10.023_bib39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.jcbfm.9600447","article-title":"Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia\/reperfusion model","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610900309X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610900309X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:04:51Z","timestamp":1760850291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999610900309X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S096999610900309X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.10.023","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic\u2013ischemic brain damage in mice is mediated by CB2 and adenosine receptors","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}